Drug monitoring detects under- and overdosing in patients receiving 5-fluorouracil-containing chemotherapy—results of a prospective, multicenter German observational study von Li, M., Mindt, S., Lück, A., Hutzschenreuter, U., Kollendt, M., Lathan, B., Zöller, T., Frank-Gleich, S., Lorentz, C., Lamberti, C., Sick, C., Zingerle, M., Tesch, H., Stein, W., Hebart, H., Stosiek, C., Sandner, R., Fries, S., Burkholder, I., Hofheinz, R.-D.

Volltext

Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG) von RÜFFER, J. U, FLECHTNER, H, TRALLS, P, JOSTING, A, SIEBER, M, LATHAN, B, DIEHL, V

Volltext

Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment von Rueffer, U., Breuer, K., Josting, A., Lathan, B., Sieber, M., Manzke, O., Grotenhermen, F.-J., Tesch, H., Bredenfeld, H., Koch, P., Nisters-Backes, H., Wolf, J., Engert, A., Diehl, V.

Volltext

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the... von DIEHL, V, FRANKLIN, J, ENGERT, A, WOLF, J, HERMANN, R, HOLMER, L, STAPPERT-JAHN, U, WINNERLEIN-TRUMP, E, WULF, G, KRAUSE, S, GLUNZ, A, VON KALLE, K, HASENCLEVER, D, BISCHOFF, H, HAEDICKE, C, DUEHMKE, E, GEORGII, A, LOEFFLER, M, TESCH, H, PFREUNDSCHUH, M, LATHAN, B, PAULUS, U, SIEBER, M, RUEFFER, J.-U, SEXTRO, M

Volltext

Low-Dose Radiation Is Sufficient for the Noninvolved Extended-Field Treatment in Favorable Early-Stage Hodgkin’s Disease: Long-Term Results of a Randomized Trial of Radiotherapy Al... von DÜHMKE, Eckhart, FRANKLIN, Jeremy, LATHAN, Bernd, RÜFFER, Ulrich, SIEBER, Markus, WOLF, Jürgen, ENGERT, Andreas, GEORGII, Axel, STAAR, Susanne, HERRMANN, Richard, BEYKIRCH, Maria, KIRCHNER, Hartmut, PFREUNDSCHUH, Michael, EMMINGER, Adelheid, GREIL, Richard, FRITSCH, Esther, KOCH, Peter, DROCHTERT, Angelika, BROSTEANU, Oana, HASENCLEVER, Dirk, LOEFFLER, Markus, DIEHL, Volker, SEHLEN, Susanne, WILLICH, Norman, RÜHL, Ursula, MÜLLER, Rolf-Peter, LUKAS, Peter, ATZINGER, Anton, PAULUS, Ursula

Volltext

Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease von Diehl, Volker, Franklin, Jeremy, Pfreundschuh, Michael, Lathan, Bernd, Paulus, Ursula, Hasenclever, Dirk, Tesch, Hans, Herrmann, Richard, Dörken, Bernd, Müller-Hermelink, Hans-Konrad, Dühmke, Eckhardt, Loeffler, Markus

Volltext

BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease von Diehl, V., Sieber, M., Rüffer, U., Lathan, B., Hasenclever, D., Pfreundschuh, M., Loeffler, M., Lieberz, D., Koch, P., Adler, M., Tesch, H.

Volltext

Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group von PFREUNDSCHUH, M. G, RUEFFER, U, LOEFFLER, M, DIEHL, V, LATHAN, B, SCHMITZ, N, BROSTEANU, O, HASNCLEVER, D, HAAS, R, KIRCHNER, H, KOCH, P, KUSE, R

Volltext

Moderate Dose Escalation for Advanced Stage Hodgkin's Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adj... von Tesch, H., Diehl, V., Lathan, B., Hasenclever, D., Sieber, M., Rüffer, U., Engert, A., Franklin, J., Pfreundschuh, M., Schalk, K.P., Schwieder, G., Wulf, G., Dölken, G., Worst, P., Koch, P., Schmitz, N., Bruntsch, U., Tirier, C., Müller, U., Loeffler, M.

Volltext

Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adj... von Tesch, H., Diehl, V., Lathan, B., Hasenclever, D., Sieber, M., Rüffer, U., Engert, A., Franklin, J., Pfreundschuh, M., Schalk, K.P., Schwieder, G., Wulf, G., Dölken, G., Worst, P., Koch, P., Schmitz, N., Bruntsch, U., Tirier, C., Müller, U., Loeffler, M.

Volltext

BEACOPP: A new regimen for advanced Hodgkin's disease von Diehl, V., Franklin, J., Hasenclever, D., Tesch, H., Pfreundschuh, M., Lathan, B., Paulus, U., Sieber, M., Rüffer, J.-U., Sextro, M., Engert, A., Wolf, J., Hermann, R., Holmer, L., Stappert-Jahn, U., Winnerlein-Trump, E., Wulf, G., Krause, S., Glunz, A., von Kalle, K., Bischoff, H., Haedicke, C., Dühmke, E., Georgii, A., Loeffler, M.

Volltext

Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF von Pfreundschuh, M., Hasenclever, D., Loeffler, M., Ehninger, G., Schmitz, N., Kirchner, H., Koch, P., Lathan, B., Rueffer, U., Sextro, M., Franklin, J., Tesch, H., Diehl, V.

Volltext

Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgk... von Diehl, V., Loeffler, M., Pfreundschuh, M., Ruehl, U., Hasenclever, D., Nisters-Backes, H., Sieber, M., Smith, K., Tesch, H., Geilen, W., Adler, M., Bartels, H., Brandenburg, U., Diezler, P., Doelken, G., Enzian, J., Fuchs, R., Gassmann, W., Gerhartz, H., Hagenaukamp, U., Hecht, T., Hiller, E., Hinkelbein, H., Lathan, B., Kirchner, H., Kuehn, G., Kuerten, H., Loos, U., Makoski, B., Oertel, W., Petsch, S., Pfab, R., Pflueger, H., Planker, M., Rohioff, R., Sack, H., Samandari, S., Sauer, R., Schalk, K., Schmitz, G., Schoppe, W., Schwieder, G., Szepesi, S., Teichmann, J., Wilhelmy, W., Worst, P., Fischer, R., Georgii, A., Huebner, K., Schwarze, E. W.

Volltext

Ruminal nitrogen disappearance from sod-seeded cereal grain forages in Northern Arkansas von Coblentz, Wayne K, Coffey, Kenneth P, Turner, James E, Scarbrough, Dean A, Weyers, Jeffrey S, Harrison, Kenneth F, Johnson, Zelpha B, Daniels, Lathan B, Rosenkrans, Charles F, Kellogg, D.Wayne, Hubbell, Donald S

Volltext

Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients von Staib, P., Lathan, B., Knöppel-Schwark, S., Tesch, H., Voliotis, D., Steinmetz, H. T., Schwonzen, M., Wickramanayake, P. D., Diehl, V.

Volltext

A Phase-II Study with Idarubicin, Ifosfamide and VP-16 (IIVP-16) in Patients with Refractory or Relapsed Aggressive and High Grade non-Hodgkin's Lymphoma von Engert, A., Schnell, R., Kñpper, F., Reiser, M., Engelhard, M., Wilhelm, M., Lathan, B., Baltes-Engler, S., Winterhalter, B., Scheulen, M. E., Dederichs, B., Tesch, H., Wörmann, B., Diehl, V.

Volltext

Rapidly Alternating COPP/ABV/IMEP Is Not Superior to Conventional Alternating COPP/ABVD in Combination With Extended-Field Radiotherapy in Intermediate-Stage Hodgkin’s Lymphoma: Fi... von Sieber, M.

Volltext

Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4 von EFFERTH, T, LATHAN, B, VOLM, M

Volltext

High-Dose Versus Intermediate Dose Cytosine Arabinoside Combined with Mitoxantrone for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia: Results of an Age Adjusted R... von Hiddemann, W., Aul, C., Maschmeyer, G., Schönrock-nabuls, R., Ludwig, W. D., Bartholomäus, A., Bettelheim, P., Becker, K., Balleisen, L., Lathan, B., Köppler, H., Grüneisen, T., Donhuijsenant, R., Reichle, A., Heinecke, A., Sauerland, C., Büchner, Th

Volltext

Workshop III: Recommendations for future clinical trials von Pfreundschuh, M., Lathan, B., Löffler, M., Röffer, U., Hasenclever, D., Diehl, V.

Volltext